- Nachrichtendetail
-
17.06.2024 08:02:42 - dpa-AFX: *ASTRAZENECA SAYS IMFINZI PLUS CHEMOTHERAPY APPROVED IN THE US FOR ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 149,850 | 26.06.24 12:04:37 | +1,150 | +0,77% | 149,600 | 149,800 | 149,400 | 148,700 |
